Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Marchesini

Showing results (1-10 of 213) with videos related to

Pageof 22
Sort By:
Minerva Cardioangiologica|June 17, 2006
Nonalcoholic fatty liver disease and the metabolic syndromeG Marchesini, M Babini
Nutrition (Burbank, Los Angeles County, Calif.)|September 29, 1999
Nutritional support with amino acids in advanced cirrhosis: a few answers, a lot of questionsG Marchesini, G Bianchi
Minerva Medica|August 25, 1984
[Hepatic coma. Therapeutic aspects]E Pisi, G Marchesini
Drugs|January 1, 1990
Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part II. Clinical consequences and potential for pharmacological intervention in cirrhosisE Pisi, G Marchesini
Comprehensive Therapy|July 1, 1977
Cell-mediated immunity in viral hepatitisD Zauli, G Marchesini
Hepatology (Baltimore, Md.)|August 1, 1989
Carbohydrate metabolism in hepatocellular carcinoma: where does the glucose go?G Marchesini, G Bianchi
IEEE Transactions on Pattern Analysis and Machine Intelligence|August 27, 2011
On the problems of constructing minimal realizations for two-dimensional filtersE Fornasini, G Marchesini
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1997
Effect of lactulose on carbohydrate metabolism and diabetes mellitusG Bianchi, M Ronchi, G Marchesini
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 9, 2016
Response to letter to the editor: Gallo F et al., "The economic burden of severe hypoglycemia: Two sides of the same coin" Nutr Metab Cardiovasc Dis. 2016;26:850-851G Veronese, G Marchesini, A Fabbri
Diabetologia|September 3, 2008
Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?G Targher, F Marra, G Marchesini
Pageof 22

Showing results (1-10 of 213) with videos related to

Sort By:
Pageof 22
Minerva Cardioangiologica|June 17, 2006
Nonalcoholic fatty liver disease and the metabolic syndromeG Marchesini, M Babini
Nutrition (Burbank, Los Angeles County, Calif.)|September 29, 1999
Nutritional support with amino acids in advanced cirrhosis: a few answers, a lot of questionsG Marchesini, G Bianchi
Minerva Medica|August 25, 1984
[Hepatic coma. Therapeutic aspects]E Pisi, G Marchesini
Drugs|January 1, 1990
Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part II. Clinical consequences and potential for pharmacological intervention in cirrhosisE Pisi, G Marchesini
Comprehensive Therapy|July 1, 1977
Cell-mediated immunity in viral hepatitisD Zauli, G Marchesini
Hepatology (Baltimore, Md.)|August 1, 1989
Carbohydrate metabolism in hepatocellular carcinoma: where does the glucose go?G Marchesini, G Bianchi
IEEE Transactions on Pattern Analysis and Machine Intelligence|August 27, 2011
On the problems of constructing minimal realizations for two-dimensional filtersE Fornasini, G Marchesini
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1997
Effect of lactulose on carbohydrate metabolism and diabetes mellitusG Bianchi, M Ronchi, G Marchesini
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 9, 2016
Response to letter to the editor: Gallo F et al., "The economic burden of severe hypoglycemia: Two sides of the same coin" Nutr Metab Cardiovasc Dis. 2016;26:850-851G Veronese, G Marchesini, A Fabbri
Diabetologia|September 3, 2008
Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?G Targher, F Marra, G Marchesini
Pageof 22